نتایج جستجو برای: remitting multiple sclerosis rrms

تعداد نتایج: 787104  

Journal: :Neurology 2013
Aurélie Ruet Mathilde Deloire Julie Charré-Morin Delphine Hamel Bruno Brochet

OBJECTIVES To characterize the cognitive abilities of patients with primary progressive multiple sclerosis (PPMS) and relapsing-remitting multiple sclerosis (RRMS) compared with healthy controls (HCs) matched for age, sex, and education level while considering the different characteristics of PPMS and RRMS and to compare the cognitive patterns of these types of multiple sclerosis. METHODS For...

2018
Katerina Ntoskou Lambros Messinis Grigorios Nasios Maria Martzoukou Giorgos Makris Elias Panagiotopoulos Panagiotis Papathanasopoulos

Objective The objective of this study was to investigate the pattern and severity of cognitive and language impairment in Greek patients with Relapsing-remitting (RRMS) and Secondary Progressive Multiple Sclerosis (SPMS), relative to control participants. Method A prospective study was conducted in 27 patients with multiple sclerosis (PwMS), (N= 15) with RRMS, (N= 12) with SPMS, and (N= 12) h...

2017
Alma Mikkola Aku Ojanen Juha E K Hartikainen Anne M Remes Sakari Simula

INTRODUCTION Multiple sclerosis is associated with prolonged cardiac repolarization but the underlying physiology has remained unknown. In this study, we compared cardiac repolarization during the relapsing-remitting multiple sclerosis (RRMS) disease course in patients with motor and sensory onset symptom. METHODS Twenty-five RRMS patients with motor and 33 RRMS patients with sensory onset sy...

Journal: :Blood 2003
Luca Battistini Laura Piccio Barbara Rossi Simona Bach Simona Galgani Claudio Gasperini Linda Ottoboni Donatella Ciabini Maria D Caramia Giorgio Bernardi Carlo Laudanna Elio Scarpini Rodger P McEver Eugene C Butcher Giovanna Borsellino Gabriela Constantin

Multiple sclerosis (MS) is considered an autoimmune inflammatory disease of the central nervous system. Under physiologic conditions, we compared the adhesiveness of CD4+ and CD8+ lymphocytes from nontreated patients with acute, relapsing-remitting multiple sclerosis (RRMS) and from healthy donors. We show that in patients with RRMS CD8+, but not with RRMS CD4+, T cells display increased rollin...

Journal: : 2023

Background: The aim of this study is to investigate the presence cognitive dysfunction and deep gray matter involvement in early-stages Relapsing-Remitting Multiple Sclerosis(RRMS) disease examine relationship between them.
 Materials Methods: Thirty-four patients 23 healthy individuals were included study. Patients diagnosed with RRMS according Revised 2010 2017 McDonald criteria, aged 18...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2005
Giuseppe Matarese Pietro Biagio Carrieri Antonio La Cava Francesco Perna Veronica Sanna Veronica De Rosa Daniela Aufiero Silvia Fontana Serafino Zappacosta

We analyzed the serum and cerebrospinal fluid (CSF) leptin secretion and the interaction between serum leptin and CD4(+)CD25+ regulatory T cells (T(Regs)) in naive-to-therapy relapsing-remitting multiple sclerosis (RRMS) patients. Leptin production was significantly increased in both serum and CSF of RRMS patients and correlated with IFN-gamma secretion in the CSF. T cell lines against human my...

2014
Athanasios Papathanasiou Lambros Messinis Vasileios L. Georgiou Panagiotis Papathanasopoulos

Objective. To investigate the pattern of cognitive impairment in relapsing remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients using a computerized battery. Methods. RRMS patients (N = 50), SPMS patients (N = 30), and controls (N = 31) were assessed by Central Nervous System Vital Signs (CNS VS) computerized battery, Trail Making Tests (TMT) A and B,...

Journal: :Archives of neurology 2009
Olaf Stüve Verena I Leussink Ruth Fröhlich Bernhard Hemmer Hans-Peter Hartung Til Menge Bernd C Kieseier

OBJECTIVE To describe 2 patients with relapsing-remitting multiple sclerosis (RRMS) receiving long-term treatment with the monoclonal antibody rituximab. The clinical and paraclinical efficacy of rituximab was demonstrated recently in a phase 2 clinical trial in patients with RRMS. DESIGN Case series. SETTING Tertiary care university medical center. PATIENTS Two young patients with highly...

Journal: :Multiple sclerosis 2017
Samia J Khoury James Rochon Linna Ding Margie Byron Kristin Ryker Patti Tosta Wendy Gao Mark S Freedman Douglas L Arnold Peter H Sayre Dawn E Smilek

BACKGROUND Costimulatory blockade of T lymphocytes with the CTLA4-Ig fusion protein abatacept could be an effective treatment for the immune-mediated neuroinflammatory disease relapsing-remitting multiple sclerosis (RRMS). OBJECTIVE To evaluate efficacy and safety of abatacept in RRMS. METHODS ACCLAIM (A Cooperative Clinical Study of Abatacept in Multiple Sclerosis) was a Phase II, randomiz...

2003
Luca Battistini Laura Piccio Barbara Rossi Simona Bach Simona Galgani Claudio Gasperini Linda Ottoboni Donatella Ciabini Maria D. Caramia Giorgio Bernardi Carlo Laudanna Elio Scarpini Rodger P. McEver Eugene C. Butcher Giovanna Borsellino

Multiple sclerosis (MS) is considered an autoimmune inflammatory disease of the central nervous system. Under physiologic conditions, we compared the adhesiveness of CD4 and CD8 lymphocytes from nontreated patients with acute, relapsing-remitting multiple sclerosis (RRMS) and from healthy donors. We show that in patients with RRMS CD8 , but not with RRMS CD4 , T cells display increased rolling ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید